phosphatidylinositol mannoside

Also Known As:

MA PH-IN; mannosyl phosphatidylinositol; mannosylphosphatidylinositol; phosphatidyl inositol mannoside; phosphatidylinositol monomannoside; phosphatidylinositomanoside; phosphoinositolmannoside

Networked: 9 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Lipids: 114793
- Membrane Lipids: 1591
  - Phospholipids: 11903
    - Glycerophosphates: 118
      - Phosphatidic Acids: 358
        Glycerophospholipids: 689
        Phosphatidylinositols: 5099
        phosphatidylinositol mannoside: 9

Experts

1.	Boom, W Henry: 3 articles (10/2018 - 09/2006)
2.	Harding, Clifford V: 3 articles (10/2018 - 09/2006)
3.	Rojas, Roxana E: 2 articles (10/2009 - 09/2006)
4.	Drage, Michael G: 1 article (10/2018)
5.	Richardson, Edward T: 1 article (10/2018)
6.	Shukla, Supriya: 1 article (10/2018)
7.	Al-Hiari, Yusuf: 1 article (01/2017)
8.	Alamiri, Amani: 1 article (01/2017)
9.	Hasan, Alaa: 1 article (01/2017)
10.	Shaheen, Omar: 1 article (01/2017)

Related Diseases

1.	Coinfection 01/01/2023 - " literature search identified the following factors that can potentially affect the reactivation of pulmonary tuberculosis in severely burned patients: decreased immune system; secondary infections; low blood albumin(protein) levels; decreased clearance of bacteria from the airways, the development of pulmonary tuberculosis biofilms (capsules that protect the bacteria from chemicals and antibiotics) and the role of a fat molecule called phosphatidylinositol mannoside in pulmonary tuberculosis.In"
2.	Pulmonary Tuberculosis 01/01/2023 - " literature search identified the following factors that can potentially affect the reactivation of pulmonary tuberculosis in severely burned patients: decreased immune system; secondary infections; low blood albumin(protein) levels; decreased clearance of bacteria from the airways, the development of pulmonary tuberculosis biofilms (capsules that protect the bacteria from chemicals and antibiotics) and the role of a fat molecule called phosphatidylinositol mannoside in pulmonary tuberculosis.In"
3.	Tuberculosis (Tuberculoses) 09/01/1992 - "Serological response to purified mycobacterial phosphatidylinositol mannoside in healthy controls and in patients with tuberculosis and leprosy." 09/01/2006 - "tuberculosis cell wall glycolipid, phosphatidylinositol mannoside (PIM), induces homotypic adhesion of human CD4+ T cells and T cell adhesion to immobilized FN. " 10/01/2018 - "tuberculosis include lipoproteins (e.g., LprG), the glycolipid phosphatidylinositol mannoside 6 (PIM6), and the lipoglycan lipomannan (LM). " 10/01/2009 - "tuberculosis cell wall glycolipids, specifically, phosphatidylinositol mannoside and mannose-capped lipoarabinomannan, were potent inhibitors. " 02/01/1995 - "tuberculosis and its cell wall components lipoarabinomannan (LAM), lipomannan (LM), and phosphoinositolmannoside (PIM) stimulated IL-8 protein release and mRNA expression in vitro from alveolar macrophages, but deacylated LAM did not. "
4.	Neoplasms (Cancer) 01/01/2017 - "Over expression of Human phosphatidyl inositol mannoside kinases isoform 1 (Pim-1 kinase) has been reported in several leukemia and solid tumors. "
5.	Leukemia 01/01/2017 - "Over expression of Human phosphatidyl inositol mannoside kinases isoform 1 (Pim-1 kinase) has been reported in several leukemia and solid tumors. "

Related Drugs and Biologics

1.	Proteins (Proteins, Gene)
2.	Anti-Bacterial Agents (Antibiotics)
3.	Albumins
4.	Glycolipids
5.	lipomannan
6.	lipoarabinomannan (LAM)
7.	Protein Isoforms (Isoforms)
8.	Interleukin-8 (Interleukin 8)
9.	Messenger RNA (mRNA)
10.	Phosphotransferases (Kinase)